Segal et al., 1995 - Google Patents
Production of bispecific antibodiesSegal et al., 1995
- Document ID
- 17339041665374228981
- Author
- Segal D
- Bast B
- Publication year
- Publication venue
- Current protocols in immunology
External Links
Snippet
Bispecific antibodies (bsAbs) contain two different binding specificities within a single molecule and can specifically bind two different molecules together. BsAbs can be produced by chemically cross‐linking purified antibodies or Fab fragments with reducible disulfide …
- 108010071919 Bispecific Antibodies 0 title abstract description 14
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material Not used, see subgroups
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Nolan et al. | Bifunctional antibodies: concept, production and applications | |
US4714681A (en) | Quadroma cells and trioma cells and methods for the production of same | |
US4474893A (en) | Recombinant monoclonal antibodies | |
JP2714786B2 (en) | Methods for producing chimeric antibodies | |
US5959084A (en) | Bispecific antibodies, methods of production and uses thereof | |
Segal et al. | Production of bispecific antibodies | |
US20070292416A1 (en) | De-Immunized Anti-Cd3 Antibody | |
Peipp et al. | Efficient eukaryotic expression of fluorescent scFv fusion proteins directed against CD antigens for FACS applications | |
JPH01501200A (en) | antibody | |
JP2004506408A (en) | Bispecific molecules and their uses | |
US20220306740A1 (en) | Bispecific binding molecules | |
EP0644900B1 (en) | A monoclonal antibody to a human mdr1 multidrug resistance gene product, and its use | |
JPH01501201A (en) | antibody | |
Jiang et al. | Characterization of bispecific antibody production in cell cultures by unique mixed mode size exclusion chromatography | |
JP2015193637A (en) | Method for treating immune disorders | |
US7011974B2 (en) | Method for producing monoclonal antibodies | |
US20240383970A1 (en) | Antibody specifically binding to strep-tag ii tag and use thereof | |
CN109265564A (en) | A kind of mouse AntiCD3 McAb recombinant immunotoxin and its preparation method and application | |
AU634980B2 (en) | Cell sorting technique and applications thereof | |
US7247475B2 (en) | Method for producing monoclonal antibodies | |
Ring et al. | Targeted Lysis of Human Breast Cancer Cells by Human Effector Cells Armed with Bispecific Antibody 2B1 (ANTI-c-erbB-2/ANTI-Fcγ Receptor III) | |
EP3784698A1 (en) | Recombinant immunoglobulins of a new igg5 class, encoded by the human heavy chain pseudo-gamma gene | |
JPH02186980A (en) | Avian thymidine kinase deficient b-lymphoblastocyte strain | |
Liu | Development of bispecific monoclonal antibodies and their applications in ultrasensitive virus ELISA; phage display technology and viral purification. | |
Brixner | Monoclonal antibodies: From the research lab to the pharmacy |